Brief: MEI Pharma To Consider Strategic Alternatives

Lite Strategy

22/07/2024 13:41

July 22 (Reuters) - MEI Pharma Inc  MEIP.O :
    * MEI PHARMA TO CONSIDER STRATEGIC ALTERNATIVES
    * MEI PHARMA INC: COMMENCES A CASH PRESERVATION PLAN
INCLUDING A
REDUCTION IN FORCE
    * MEI PHARMA INC - COMPANY WILL COMMENCE A
REDUCTION-IN-FORCE
    * MEI PHARMA INC - TO DISCONTINUE VORUCICLIB DEVELOPMENT
    * MEI PHARMA INC -  WILL CONSIDER OPTIONS SUCH AS
OUT-LICENSING
OPPORTUNITIES FOR EXISTING PROGRAMS AND MERGER AND ACQUISITION
OPPORTUNITIES
    * MEI PHARMA INC - CEO AND CMO TO STEP DOWN
    * MEI PHARMA INC - CHAIRPERSON CHARLES BALTIC III TO STEP
DOWN
    * MEI PHARMA INC - APPOINTED JUSTIN "JAY" FILE, TO ASSUME
POSITION
OF ACTING CHIEF EXECUTIVE OFFICER UPON URSO'S DEPARTURE
    * MEI PHARMA INC - APPOINTS JUSTIN FILE AS ACTING CEO
    * MEI PHARMA INC - APPOINTS FREDERICK W. DRISCOLL AS
CHAIRPERSON

Source text for Eikon:  ID:nBw5hsq3na 
Further company coverage:  MEIP.O 

 ((Reuters.Briefs@thomsonreuters.com;))